112 related articles for article (PubMed ID: 8208623)
1. An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer.
Vieweg J; Heston WD; Gilboa E; Fair WR
Prostate; 1994 Jun; 24(6):291-8. PubMed ID: 8208623
[TBL] [Abstract][Full Text] [Related]
2. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer.
La Perle KM; Shen D; Buckwalter TL; Williams B; Haynam A; Hinkle G; Pozderac R; Capen CC; Jhiang SM
Prostate; 2002 Feb; 50(3):170-8. PubMed ID: 11813209
[TBL] [Abstract][Full Text] [Related]
3. Factors in prostate cancer metastasis.
Geldof AA; Rao BR
Anticancer Res; 1990; 10(5A):1303-6. PubMed ID: 2241106
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic placement of the Dunning R3327 AT-3 prostate tumor in the Copenhagen X Fischer rat.
Rubenstein M; Saffrin R; Shaw M; Muchnik S; Guinan P
Prostate; 1995 Sep; 27(3):148-53. PubMed ID: 7567693
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.
Momma T; Hamblin MR; Wu HC; Hasan T
Cancer Res; 1998 Dec; 58(23):5425-31. PubMed ID: 9850075
[TBL] [Abstract][Full Text] [Related]
6. High-malignancy orthotopic nude mouse model of human prostate cancer LNCaP.
Wang X; An Z; Geller J; Hoffman RM
Prostate; 1999 May; 39(3):182-6. PubMed ID: 10334107
[TBL] [Abstract][Full Text] [Related]
7. Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice.
An Z; Wang X; Geller J; Moossa AR; Hoffman RM
Prostate; 1998 Feb; 34(3):169-74. PubMed ID: 9492844
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin treatment increases metastasis of prostate tumor (R3327-MatLyLu).
Geldof AA; Rao BR
Anticancer Res; 1988; 8(6):1335-9. PubMed ID: 3218966
[TBL] [Abstract][Full Text] [Related]
9. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
10. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
[TBL] [Abstract][Full Text] [Related]
11. A novel mouse model of human prostate cancer to study intraprostatic tumor growth and the development of lymph node metastases.
Linxweiler J; Körbel C; Müller A; Hammer M; Veith C; Bohle RM; Stöckle M; Junker K; Menger MD; Saar M
Prostate; 2018 Jun; 78(9):664-675. PubMed ID: 29572953
[TBL] [Abstract][Full Text] [Related]
12. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
[TBL] [Abstract][Full Text] [Related]
13. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
[TBL] [Abstract][Full Text] [Related]
14. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study.
Kim IY; Modi PK; Sadimin E; Ha YS; Kim JH; Skarecky D; Cha DY; Wambi CO; Ou YC; Yuh B; Park S; Llukani E; Albala DM; Wilson T; Ahlering T; Badani K; Ahn H; Lee DI; May M; Kim WJ; Lee DH
J Urol; 2013 Aug; 190(2):527-34. PubMed ID: 23485503
[TBL] [Abstract][Full Text] [Related]
15. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant radiotherapy for lymph-node-positive prostate cancer with low tumor load after radical prostatectomy : Multicenter randomized phase III study of the effect of adjuvant radiotherapy in patients with prostate cancer with or without a positive margin after radical prostatectomy (RP) and lymph node metastasis with low tumor load (micrometastases, ≤ 2 lymph node macrometastases). ART-2 - study AP 61/10 of the AUO].
Rexer H; Bartkowiak D
Urologe A; 2017 Aug; 56(8):1040-1043. PubMed ID: 28667345
[No Abstract] [Full Text] [Related]
17. Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy.
Tilki D; Mandel P; Seeliger F; Kretschmer A; Karl A; Ergün S; Seitz M; Stief CG
J Urol; 2015 Feb; 193(2):484-90. PubMed ID: 25180792
[TBL] [Abstract][Full Text] [Related]
18. Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps.
Hautmann S; Huland E; Wullbrand A; Friedrich M; Huland H
Anticancer Res; 2000; 20(6B):4495-8. PubMed ID: 11205294
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer.
Rembrink K; Romijn JC; van der Kwast TH; Rübben H; Schröder FH
Prostate; 1997 May; 31(3):168-74. PubMed ID: 9167768
[TBL] [Abstract][Full Text] [Related]
20. Prostatic tumor (R3327) skeletal metastasis.
Geldof AA; Rao BR
Prostate; 1990; 16(4):279-90. PubMed ID: 2371174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]